Decheng Capital as of Sept. 30, 2024
Portfolio Holdings for Decheng Capital
Decheng Capital holds 26 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 49.0 | $207M | 5.5M | 37.73 | |
| Nuvation Bio (NUVB) | 14.1 | $59M | 26M | 2.29 | |
| Phathom Pharmaceuticals (PHAT) | 5.4 | $23M | 1.3M | 18.08 | |
| Arcus Biosciences Incorporated (RCUS) | 3.1 | $13M | 870k | 15.29 | |
| Krystal Biotech (KRYS) | 3.1 | $13M | 72k | 182.03 | |
| Illumina (ILMN) | 2.9 | $12M | 95k | 130.41 | |
| Zentalis Pharmaceuticals (ZNTL) | 2.7 | $11M | 3.1M | 3.68 | |
| BeyondSpring SHS (BYSI) | 2.7 | $11M | 5.0M | 2.29 | |
| Newamsterdam Pharma Co Nv (NAMS) | 2.3 | $9.8M | 590k | 16.60 | |
| Merus N V (MRUS) | 2.2 | $9.4M | 189k | 49.96 | |
| Helix Acquisition Corp | 2.0 | $8.4M | 167k | 50.42 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.9 | $8.1M | 158k | 51.10 | |
| Legend Biotech Corp- Adr (LEGN) | 1.3 | $5.3M | 109k | 48.73 | |
| Cytokinetics (CYTK) | 1.2 | $5.0M | 94k | 52.80 | |
| Aura Biosciences (AURA) | 1.1 | $4.6M | 516k | 8.91 | |
| GeneDx Holdings Corp. Com Cl A (WGS) | 1.0 | $4.4M | 104k | 42.44 | |
| 4d Molecular Therapeutics In (FDMT) | 1.0 | $4.3M | 398k | 10.81 | |
| Equillium (EQ) | 0.9 | $3.7M | 4.4M | 0.83 | |
| Vera Therapeutics (VERA) | 0.7 | $3.1M | 70k | 44.20 | |
| Longboard Pharmaceuticals In | 0.4 | $1.9M | 56k | 33.33 | |
| Arcellx (ACLX) | 0.4 | $1.8M | 21k | 83.51 | |
| Pyxis Oncology (PYXS) | 0.3 | $1.2M | 327k | 3.67 | |
| AtriCure (ATRC) | 0.2 | $751k | 27k | 28.04 | |
| Grail (GRAL) | 0.0 | $133k | 9.7k | 13.76 | |
| Revolution Medicines (RVMD) | 0.0 | $91k | 2.0k | 45.35 | |
| Nuvation Bio Warrants (NUVB.WS) | 0.0 | $63k | 646k | 0.10 |
